SCHEMBL1274433

SCHEMBL1274433

CC(C)CC(=CS(=O)(=O)O)C(N)=O

nearest known ligand 0.43

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.34
TDP1 Q9NUW8 1/20 0.34
KISS1R Q969F8 2/20 0.33
CA2 P00918 1/20 0.32
GRIK1 P39086 1/20 0.30
POLB P06746 1/20 0.30
NPSR1 Q6W5P4 1/20 0.30
L3MBTL1 Q9Y468 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28046115 0.76 ALDH1A1 (0.42) ALDH1A1TDP1KISS1RCA2GRIK1
SCHEMBL5580596 0.73 CES2 (0.33) ALDH1A1
SCHEMBL28095839 0.71 GRIK1 (0.46) ALDH1A1TDP1KISS1RCA2GRIK1
SCHEMBL2397901 0.71 GRIK1 (0.52) ALDH1A1TDP1KISS1RCA2GRIK1
SCHEMBL2397898 0.71 GRIK1 (0.52) ALDH1A1TDP1KISS1RCA2GRIK1
SCHEMBL22500308 0.69 ALDH1A1 (0.36) ALDH1A1TDP1KISS1RCA2GRIK1
SCHEMBL2911133 0.68 GRIK1 (0.35) GRIK1
Isovaleramide SCHEMBL30731383 0.67 ALDH1A1 (0.42) ALDH1A1TDP1CA2POLBNPSR1
Sulfuric Acid SCHEMBL36970 0.67 TDP1 (0.37) ALDH1A1TDP1CA2GRIK1POLB
SCHEMBL11340815 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250129391-A1 SYSTEM AND METHOD FOR CONTROLLED POLYMER DEPOLYMERIZATION Intropic Materials Corporation (US) 2025-04-24 US disclosed
WO-2025085828-A1 SYSTEM AND METHOD FOR CONTROLLED POLYMER DEPOLYMERIZATION Intropic Materials Corporation (US) 2025-04-24 WO disclosed
EP-1248796-B1 PROCESS FOR THE PURIFICATION OF ANTITHROMBIN-III OCTAPHARMA AG (CH) 2011-03-16 EP disclosed
EP-2284187-A2 Process for the purification of antithrombin-III Octapharma AG (CH) 2011-02-16 EP disclosed
EP-1248796-A1 PROCESS FOR THE PURIFICATION OF ANTOTHROMBIN-III BIOVITRUM AB (SE) 2002-10-16 EP disclosed
US-6451978-B2 PURE ANTITHROMBIN-III, THE ANTITHROMBIN ISOFORMS AT-III ALPHA AND AT-III BETA, AND/OR HISTIDINE-RICH GLYCOPROTEIN BY USNG A CATION EXCHANGE GEL WHEREIN THE CATION EXCHANGER GROUP IS ATTACHED TO THE GEL MATRIX BY A LINEAR POLYMER CHAIN BIOVITRUM AB (SE) 2002-09-17 US disclosed
US-20010034053-A1 Protein purification I BIOVITRUM AB (SE) 2001-10-25 US disclosed
WO-2001053328-A1 PROCESS FOR THE PURIFICATION OF ANTOTHROMBIN-III BIOVITRUM AB (SE) 2001-07-26 WO disclosed
US-6136925-A GRAFT POLYMERIZATION WITH SULFOETHYLACRYLAMIDE; CHROMATOGRAPHY MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DE) 2000-10-24 US disclosed
EP-0789620-B1 SEPARATING MATERIALS AND PROCESS FOR THEIR PREPARATION MERCK PATENT GMBH (DE) 2000-06-07 EP disclosed
EP-0789620-A1 SEPARATING MATERIALS AND PROCESS FOR THEIR PREPARATION MERCK PATENT GmbH (DE) 1997-08-20 EP disclosed
WO-1996014151-A9 SEPARATING MATERIALS AND PROCESS FOR THEIR PREPARATION 1996-08-15 WO disclosed
WO-1996014151-A1 SEPARATING MATERIALS AND PROCESS FOR THEIR PREPARATION MERCK PATENT GMBH (DE) 1996-05-17 WO disclosed